title: Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization.
abstract: OBJECTIVE
  To assess the conflicting evidence whether low-dose aspirin is beneficial in IVF and to evaluate the meta-analysis performed by Gelbaya et al. and reported in March 2007 in Human Reproduction Update, in which they found no effects of low-dose aspirin and recommended discontinuing its use in IVF. We present a reanalysis of the effects of low-dose aspirin in IVF and raise methodological questions regarding the analysis by Gelbaya et al.
  
  
  METHODS
  A meta-analysis of prospective randomized trials evaluating the effects of low-dose aspirin in IVF.
  
  
  METHODS
  Women undergoing IVF/intracytoplasmic sperm injection.
  
  
  METHODS
  Low-dose acetylsalicylic acid (aspirin).
  
  
  METHODS
  Pregnancy rates, implantation rates, miscarriage rates.
  
  
  RESULTS
  Ten randomized clinical trials were included in the analysis. Clinical pregnancy rate per ET was significant when low-dose aspirin was compared with no treatment (risk ratio 1.15, 95% confidence interval 1.03-1.27). Nonsignificant estimates comparing low-dose aspirin with no treatment were found for implantation and miscarriage rates.
  
  
  CONCLUSIONS
  Our results suggest that aspirin may increase clinical pregnancy rates and that more data are needed to resolve the issue. At this point, there is no reason to change clinical management and discontinue the use of aspirin.
authors: Division of Epidemiology, Statistics and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20852, USA.
authors: Marcus D
authors: MD
authors: Ruopp
authors: Tara C
authors: TC
authors: Collins
authors: Brian W
authors: BW
authors: Whitcomb
authors: Enrique F
authors: EF
authors: Schisterman
mesh_terms: D000022:Abortion, Spontaneous; D001241:Aspirin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D010064:Embryo Implantation / Q000187:drug effects; D019317:Evidence-Based Medicine; D005260:Female; D005307:Fertilization in Vitro / Q000187:drug effects*; D006801:Humans; D015201:Meta-Analysis as Topic; D011247:Pregnancy; D018873:Pregnancy Rate; D012107:Research Design; D020554:Sperm Injections, Intracytoplasmic / Q000187:drug effects*; D016896:Treatment Outcome
chemical_list: D001241:Aspirin